SREBF1 and metabolic dysfunction-associated steatotic liver disease: A recent study demonstrated that Lactobacillus plantarum NA136 could activate the AMPK signaling pathway to suppress the SREBP-1/FAS signaling, which in turn inhibits de novo lipogenesis in mice with NAFLD (Zhao et al. 2019).